Pharming Group Lauded for Rare Disease Treatment
PremiumCompany AnnouncementsPharming Group Lauded for Rare Disease Treatment
3M ago
Pharming Completes Trial Enrollment for Pediatric Drug
PremiumCompany Announcements
Pharming Completes Trial Enrollment for Pediatric Drug
4M ago
Joenja’s Journey: Navigating the Market Risks and Regulatory Challenges Post-Approval for Pharming Group Nv
PremiumCompany Announcements
Joenja’s Journey: Navigating the Market Risks and Regulatory Challenges Post-Approval for Pharming Group Nv
4M ago
Pharming management to meet with Oppenheimer
PremiumThe FlyPharming management to meet with Oppenheimer
8M ago
Pharming management to meet with Oppenheimer
PremiumThe Fly
Pharming management to meet with Oppenheimer
8M ago
Pharming Group price target raised to EUR 1.90 from EUR 1.80 at RBC Capital
PremiumThe Fly
Pharming Group price target raised to EUR 1.90 from EUR 1.80 at RBC Capital
12M ago
Pharming Novartis announces first commercial shipments of Joenja in U.S.
PremiumThe FlyPharming Novartis announces first commercial shipments of Joenja in U.S.
1y ago
Pharming initiated with an Outperform at RBC Capital
PremiumThe Fly
Pharming initiated with an Outperform at RBC Capital
1y ago
Pharming price target raised to $40 from $36 at Oppenheimer
PremiumThe Fly
Pharming price target raised to $40 from $36 at Oppenheimer
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100